Nass Valley Gateway Ltd. (NSVGF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -1.31 Million CAD | 59.51% |
| 2021 | -192.92 Thousand CAD | -58.01% |
| 2020 | -309.28 Thousand CAD | -326.99% |
| 2019 | -607.81 Thousand CAD | -489.46% |
| 2018 | -103.11 Thousand CAD | 7.41% |
| 2017 | -111.36 Thousand CAD | -38.44% |
| 2016 | -80.43 Thousand CAD | 71.64% |
| 2015 | -283.64 Thousand CAD | -214.45% |
| 2014 | -90.2 Thousand CAD | 52.35% |
| 2013 | -189.32 Thousand CAD | 44.25% |
| 2012 | -339.61 Thousand CAD | -167.5% |
| 2011 | 503.1 Thousand CAD | 291.02% |
| 2010 | -263.37 Thousand CAD | -258.77% |
| 2009 | 165.87 Thousand CAD | 161.04% |
| 2008 | -271.73 Thousand CAD | 45.49% |
| 2007 | -498.48 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -17.26 Thousand CAD | -79.51% |
| 2023 Q1 | -9616.00 CAD | 99.39% |
| 2023 Q3 | -78.07 Thousand CAD | -352.32% |
| 2022 Q2 | -393.93 Thousand CAD | -60.36% |
| 2022 Q1 | -245.65 Thousand CAD | 26.77% |
| 2022 FY | - CAD | 59.51% |
| 2022 Q4 | -1.56 Million CAD | -164.6% |
| 2022 Q3 | -592.26 Thousand CAD | -50.34% |
| 2021 Q3 | -423.58 Thousand CAD | 74.59% |
| 2021 Q4 | -335.43 Thousand CAD | 20.81% |
| 2021 FY | - CAD | -58.01% |
| 2021 Q1 | -1.85 Million CAD | 20.76% |
| 2021 Q2 | -1.66 Million CAD | 9.91% |
| 2020 FY | - CAD | -326.99% |
| 2020 Q1 | -186.93 Thousand CAD | 90.37% |
| 2020 Q2 | -111.76 Thousand CAD | 40.21% |
| 2020 Q3 | -250.39 Thousand CAD | -124.03% |
| 2020 Q4 | -2.33 Million CAD | -832.57% |
| 2019 Q2 | -62.13 Thousand CAD | 68.07% |
| 2019 Q1 | -194.6 Thousand CAD | -100.67% |
| 2019 FY | - CAD | -489.46% |
| 2019 Q3 | -6680.00 CAD | 89.25% |
| 2019 Q4 | -1.94 Million CAD | -28970.94% |
| 2018 Q3 | -12.74 Thousand CAD | 65.67% |
| 2018 FY | - CAD | 7.41% |
| 2018 Q1 | -26.91 Thousand CAD | 4.33% |
| 2018 Q4 | -96.97 Thousand CAD | -661.14% |
| 2018 Q2 | -37.11 Thousand CAD | -37.89% |
| 2017 Q4 | -28.13 Thousand CAD | -94.06% |
| 2017 Q3 | -14.49 Thousand CAD | 61.66% |
| 2017 Q2 | -37.81 Thousand CAD | -22.3% |
| 2017 Q1 | -30.91 Thousand CAD | -5.46% |
| 2017 FY | - CAD | -38.44% |
| 2016 FY | - CAD | 71.64% |
| 2016 Q3 | -13.45 Thousand CAD | 46.38% |
| 2016 Q2 | -25.09 Thousand CAD | -99.59% |
| 2016 Q1 | -12.57 Thousand CAD | 94.77% |
| 2016 Q4 | -29.31 Thousand CAD | -117.86% |
| 2015 Q1 | -10.5 Thousand CAD | 38.86% |
| 2015 FY | - CAD | -214.45% |
| 2015 Q4 | -240.62 Thousand CAD | -5172.18% |
| 2015 Q3 | 4744.00 CAD | 112.73% |
| 2015 Q2 | -37.25 Thousand CAD | -254.64% |
| 2014 Q4 | -17.18 Thousand CAD | -13.03% |
| 2014 FY | - CAD | 52.35% |
| 2014 Q1 | -24 Thousand CAD | 41.19% |
| 2014 Q3 | -15.2 Thousand CAD | 55.05% |
| 2014 Q2 | -33.82 Thousand CAD | -40.92% |
| 2013 Q1 | -31.95 Thousand CAD | 72.81% |
| 2013 FY | - CAD | 44.25% |
| 2013 Q4 | -40.81 Thousand CAD | 34.4% |
| 2013 Q3 | -62.21 Thousand CAD | -14.48% |
| 2013 Q2 | -54.34 Thousand CAD | -70.05% |
| 2012 Q2 | -70.22 Thousand CAD | -22.05% |
| 2012 Q1 | -57.53 Thousand CAD | -108.97% |
| 2012 Q3 | -99.87 Thousand CAD | -42.22% |
| 2012 Q4 | -117.51 Thousand CAD | -17.66% |
| 2012 FY | - CAD | -167.5% |
| 2011 FY | - CAD | 291.02% |
| 2011 Q1 | -42.69 Thousand CAD | 43.78% |
| 2011 Q4 | 641.22 Thousand CAD | 1700.27% |
| 2011 Q2 | -55.36 Thousand CAD | -29.68% |
| 2011 Q3 | -40.07 Thousand CAD | 27.62% |
| 2010 Q4 | -75.94 Thousand CAD | -30.66% |
| 2010 Q3 | -58.12 Thousand CAD | 32.16% |
| 2010 Q2 | -85.67 Thousand CAD | -96.36% |
| 2010 Q1 | -43.63 Thousand CAD | -36.66% |
| 2010 FY | - CAD | -258.77% |
| 2009 Q1 | -47.53 Thousand CAD | -30.23% |
| 2009 Q4 | -31.92 Thousand CAD | 11.05% |
| 2009 Q3 | -35.89 Thousand CAD | 32.61% |
| 2009 Q2 | -53.26 Thousand CAD | -12.04% |
| 2009 FY | - CAD | 161.04% |
| 2008 Q3 | -53.79 Thousand CAD | 40.18% |
| 2008 Q1 | -91.52 Thousand CAD | 50.18% |
| 2008 FY | - CAD | 45.49% |
| 2008 Q4 | -36.5 Thousand CAD | 32.14% |
| 2008 Q2 | -89.91 Thousand CAD | 1.75% |
| 2007 Q3 | -86.46 Thousand CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2007 Q4 | -183.69 Thousand CAD | -112.44% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| China Medicine Corporation | 13.27 Million USD | 109.902% |
| DH Enchantment Inc. | -145.23 Thousand USD | -805.301% |
| Exlites Holdings International, Inc. | -90.49 Thousand USD | -1352.896% |
| Itonis, Inc. | -38.31 Thousand USD | -3331.921% |
| One Step Vending Corp. | -26.55 Thousand USD | -4851.676% |
| MediPal Holdings Corporation | 431.52 Million USD | 100.305% |
| PD-Rx Pharmaceuticals, Inc. | -51.41 Thousand USD | -2456.971% |
| Pharmagen, Inc. | -2.89 Million USD | 54.562% |
| Suzuken Co., Ltd. | 340.78 Million USD | 100.386% |